Transgene S.A. (0OCQ.L) LSE

Currency In EUR

AD

Valuation

Market Cap138.55M
Enterprise Value133.95M
P/E Ratio-4.36
PEG Ratio-0.1
Price/Sales Ratio647.19
Price/Book Ratio1.83
Enterprise/Revenue640.58
Enterprise/EBITDA-5.34

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-108.3
Operating Margin-124.39
AD

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.29

Income Statement

Revenue137,000
Revenue/Share0
Gross Profit0
EBITDA-39.77M
Net Income-37.52M
Diluted EPS-0.26

Balance Sheet

Total Cash92.84M
Total Cash/Share0.34
Total Debt2.18M
Total Debt/Equity0.02
Current Ratio9.4
Book Value Per Share0.4

Price History

52-Week Change-38.57
52-Week High1.35
52-Week Low0.68
Moving Average 50 Days0.77
Moving Average 200 Days0.83

Statistics

Average Volume2,119
Shares Outstanding144.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor40:39
Last Split DateJune 20, 2019
AD